| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10513873 | Journal of Clinical Epidemiology | 2013 | 5 Pages |
Abstract
Almost one-third of ventilated patients develop VAP. Vigilance for the development of VAP has to be kept on those requiring >4 days of MV. Klebsiella and Staphylococcus aureus were common bacterial isolates in such patients.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Shally Awasthi, Mohammad Tahazzul, Ankur Ambast, Yogesh C. Govil, Amita Jain,